Hearst feature weighs pinealon sleep claims against thin research base
Most-cited evidence is a 2012 rat study and two small traumatic brain injury trials, one reporting 59.4 percent working-memory improvement.
PR
By Priya Raman · Science Reporter
Oct 5 15:25 ETSource: AOL.com
The wire
- 01AOL/Hearst reviews pinealon, the EDR peptide said to act on pineal gland gene expression, after Andrew Huberman reported his REM sleep doubled during a 4- to 6-month self-experiment with pinealon and glycine.
- 02Sleep and nootropic peptides are moving through influencer channels faster than data, and clinicians will field questions about pinealon from patients citing podcast anecdotes.
- 03Published work is limited to a 2012 aged-rat study, a 10-day study in two monkeys, and two small traumatic brain injury trials; pinealon derives from Cortexin, a neuroprotective drug used in Russia.
From the source
Read at aol.comAmerica Has a Sleep Crisis. Could This Experimental Peptide Help?
"Hearst Magazines and AOL may earn commission or revenue on some items through these links."
